Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Omnicell Inc (OMCL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,375,287
  • Shares Outstanding, K 39,626
  • Annual Sales, $ 787,310 K
  • Annual Income, $ 37,730 K
  • 36-Month Beta 1.18
  • Price/Sales 4.24
  • Price/Cash Flow 28.90
  • Price/Book 4.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.23
  • Number of Estimates 4
  • High Estimate 0.23
  • Low Estimate 0.22
  • Prior Year 0.07
  • Growth Rate Est. (year over year) +228.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.40 +38.13%
on 01/30/19
86.22 -0.03%
on 02/22/19
+20.79 (+31.79%)
since 01/22/19
3-Month
56.96 +51.32%
on 12/24/18
86.22 -0.03%
on 02/22/19
+15.52 (+21.96%)
since 11/21/18
52-Week
41.25 +108.95%
on 03/01/18
86.22 -0.03%
on 02/22/19
+41.99 (+95.00%)
since 02/22/18

Most Recent Stories

More News
Factors of Influence in 2019, Key Indicators and Opportunity within Procter & Gamble, Hertz Global, NN, Omnicell, BioDelivery Sciences International, and Movado Group -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Procter & Gamble Company (NYSE:PG),...

OMCL : 86.19 (+1.20%)
NNBR : 10.60 (-0.75%)
MOV : 34.18 (+1.67%)
PG : 100.25 (+0.47%)
BDSI : 5.00 (+5.71%)
HTZ : 18.77 (+1.19%)
Allscripts Healt is Among the Companies in the Health Care Technology Industry with the Best Relative Performance (MDRX , OMCL , CERN , HMSY , VEEV )

We looked at the Health Care Technology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. ...

CERN : 57.73 (+0.87%)
OMCL : 86.19 (+1.20%)
MDRX : 10.60 (-11.22%)
Uptrend Call Working As Omnicell Inc Stock Rises 24.8% (OMCL)

SmarTrend identified an Uptrend for Omnicell Inc (NASDAQ:OMCL) on January 8th, 2019 at $62.96. In approximately 1 month, Omnicell Inc has returned 24.79% as of today's recent price of $78.56.

OMCL : 86.19 (+1.20%)
After Yesterday's Rally of 2.83% Shares Could Potentially Pullback

Omnicell Inc (NASDAQ:OMCL) traded in a range yesterday that spanned from a low of $75.50 to a high of $78.97. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $77.39...

OMCL : 86.19 (+1.20%)
Omnicell to Feature Vision for Fully Digitized, Autonomous Pharmacy at HIMSS19

Omnicell, Inc., (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will be showcasing the industry's most comprehensive and...

OMCL : 86.19 (+1.20%)
Omnicell (OMCL) Q4 Earnings Beat Estimates, Revenues Miss

Omnicell (OMCL) steadily benefits from product introductions, strategic alliances and digital conversions.

OMCL : 86.19 (+1.20%)
ABT : 76.13 (+1.32%)
ANGO : 23.00 (+2.54%)
CNMD : 75.77 (+0.84%)
Omnicell (OMCL) Q4 Earnings Surpass Estimates

Omnicell (OMCL) delivered earnings and revenue surprises of 4.48% and -1.35%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

OMCL : 86.19 (+1.20%)
Omnicell: 4Q Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Thursday reported fourth-quarter earnings of $14.8 million.

OMCL : 86.19 (+1.20%)
Omnicell Reports Results for Fiscal Year and Fourth Quarter 2018

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its fiscal year and fourth quarter ended December 31,...

OMCL : 86.19 (+1.20%)
Omnicell Solid on Geographic Expansion Amid Stiff Competition

Omnicell (OMCL) gains from expanding into new markets. Stiff rivalry is a concern.

OMCL : 86.19 (+1.20%)
VAR : 133.02 (+0.99%)
ANGO : 23.00 (+2.54%)
CNMD : 75.77 (+0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade OMCL with:

Business Summary

Omnicell, Inc. is a leading provider of medication and supply management automation, analytics software, and medication adherence solutions for healthcare organizations. It works with healthcare providers to drive operational efficiency by removing tedious tasks and waste. Regardless of distribution...

See More

Key Turning Points

2nd Resistance Point 87.22
1st Resistance Point 86.71
Last Price 86.19
1st Support Level 85.19
2nd Support Level 84.18

See More

52-Week High 86.22
Last Price 86.19
Fibonacci 61.8% 69.04
Fibonacci 50% 63.74
Fibonacci 38.2% 58.43
52-Week Low 41.25

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar